scholarly article | Q13442814 |
P2093 | author name string | Kazuhiro Watanabe | |
Takao Shimizu | |||
Yosuke Watanabe | |||
Kiyotaka Kugiyama | |||
Daisuke Fujioka | |||
Hideto Mishina | |||
Jun-ei Obata | |||
Kenichi Kawabata | |||
Shun Tamaru | |||
Takamitsu Nakamura | |||
Yoshihiro Kita | |||
Yukio Saito | |||
P2860 | cites work | Reduction in myocardial ischemia/reperfusion injury in group X secretory phospholipase A2-deficient mice | Q46573266 |
Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). | Q46847925 | ||
TNFR1 and TNFR2 signaling interplay in cardiac myocytes. | Q46968897 | ||
Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning | Q47226424 | ||
Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner | Q47388835 | ||
Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats | Q47395547 | ||
Stimulation of p38 phosphorylation and activity by arachidonic acid in HeLa cells, HL60 promyelocytic leukemic cells, and human neutrophils. Evidence for cell type-specific activation of mitogen-activated protein kinases. | Q47827873 | ||
Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. | Q48580352 | ||
Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury. | Q54625811 | ||
Role of phospholipases A2 and C in myocardial ischemic reperfusion injury | Q70112745 | ||
Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion | Q73857227 | ||
Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha | Q77846069 | ||
Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog | Q79495195 | ||
On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes | Q28592582 | ||
Phospholipase A(2). | Q34219384 | ||
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway | Q34298555 | ||
Properties and regulation of cytosolic phospholipase A2. | Q34430575 | ||
Phospholipase A(2) regulation of arachidonic acid mobilization | Q34980661 | ||
Role of caspases in TNF-mediated regulation of cPLA(2). | Q34980674 | ||
Phospolipase A2 and apoptosis | Q35047115 | ||
Group IV cytosolic phospholipase A2 (PLA2) function: insights from the knockout mouse. | Q35094325 | ||
Secretory phospholipase A2. | Q35860497 | ||
Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. | Q36182300 | ||
Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis | Q36300832 | ||
Role of cytochrome P450 in phospholipase A2- and arachidonic acid-mediated cytotoxicity | Q36380293 | ||
Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s. | Q36589972 | ||
Control of phospholipase A2 activities for the treatment of inflammatory conditions | Q36595394 | ||
Roles of cPLA2alpha and arachidonic acid in cancer | Q36629023 | ||
Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation | Q37286185 | ||
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease | Q37679415 | ||
TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure | Q37771751 | ||
Membrane phospholipid metabolism during myocardial ischaemia: past, present and future | Q39672594 | ||
A single intravenous sTNFR-Fc administration at the time of reperfusion limits infarct size--implications in reperfusion strategies in man. | Q40061409 | ||
Myocardial phospholipase A2. | Q41088064 | ||
Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor | Q41553089 | ||
Phospholipase A2-mediated hydrolysis of cardiac phospholipids: the use of molecular and transgenic techniques | Q41740251 | ||
The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning | Q42442474 | ||
Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes | Q42852578 | ||
Deletion of cytosolic phospholipase A2 promotes striated muscle growth | Q44479229 | ||
Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury. | Q44749581 | ||
P433 | issue | 10 | |
P921 | main subject | reperfusion injury | Q1413991 |
P304 | page(s) | H2018-30 | |
P577 | publication date | 2012-03-16 | |
P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
P1476 | title | Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway | |
P478 | volume | 302 |